Skip to main content

Next-Generation Sequencing in Childhood-Onset Epilepsies: Diagnostic Yield and Impact on Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease Diagnosis

Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis

Authors: Gall K, Izzo E, Seppälä EH, Alakurtti K, Koskinen L, Saarinen I, Singh A, Myllykangas S, Koskenvuo J, Alastalo T-P

PLoS One. 2021 Sep 1;16(9):e0255933. doi:10.1371/journal.pone.0255933. eCollection 2021.Disclaimer:

One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Specialties: Genetics, Neurology, Pediatrics